Immunodiagnostic Chips

Microfluidic chips for performing immunoassays with reduced sample and reagent volumes, providing rapid results for clinical diagnostics.

Microfluidic diagnostic chips designed for precise detection and diagnosis of tumors, infectious diseases, chronic conditions, and genetic disorders. These chips integrate microfluidic technology with multiple analytical platforms including fluorescent PCR, isothermal amplification, and immunoassay for applications in cancer screening, disease diagnosis, and therapeutic monitoring.

Microfluidic diagnostic chips for biochemical analysis and detection in clinical and research laboratories.

Biosensor chips for point-of-care diagnostics and laboratory testing. These chips enable rapid detection of biomarkers through microfluidic technology, supporting applications in disease screening, glucose monitoring, and clinical analysis. Designed for integration into diagnostic platforms requiring real-time measurement capabilities.

Microfluidic biochips specifically engineered for liquid biopsy applications, enabling detection and analysis of circulating biomarkers. These chips support early disease detection and monitoring through minimally invasive sampling.

Microfluidic biochips designed for liquid biopsy applications, enabling non-invasive detection of circulating biomarkers for cancer and disease diagnostics. The chips integrate sample preparation, separation, and detection capabilities in a compact format, supporting rapid analysis with minimal sample volumes for clinical screening and monitoring.

Microfluidic blood analysis chips for point-of-care white blood cell differentiation and classification. These disposable chips replace traditional fluid pathway systems in portable hematology analyzers, enabling rapid 1-minute detection of bacterial/viral infections and immune status assessment in clinical, diagnostic, and field settings.

Precision microfluidic chip devices for organ modeling, cell culture, droplet generation, and biochemical detection applications in research and clinical diagnostics.

POCT (Point-of-Care Testing) microfluidic chips enable rapid diagnostic testing at the patient bedside or clinical setting. These biochips integrate sample preparation, reagent delivery, and detection in a single disposable device, supporting applications in clinical diagnostics, infectious disease screening, and rapid biomarker detection. The chips feature microfluidic channel architecture with integrated biological surface modifications for enhanced assay performance.

Microfluidic biochips designed for point-of-care testing applications. These chips enable rapid diagnostic analysis with minimal sample volumes, supporting quick clinical decision-making in various healthcare settings.

Microfluidic platforms for immunological diagnostic assays. Enables rapid biomarker detection with reduced reagent consumption.

Infectious disease detection kits utilizing microfluidic chip, fluorescence quantitative PCR, and isothermal amplification technologies for rapid pathogen identification and diagnosis. Designed for epidemic screening, disease diagnosis, and clinical monitoring across multiple infectious disease applications.